{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:17:02Z","timestamp":1792318622434,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["RED-00110-23"],"award-info":[{"award-number":["RED-00110-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["RED-00170\\u201323"],"award-info":[{"award-number":["RED-00170\\u201323"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["407779\/2021\\u20133"],"award-info":[{"award-number":["407779\/2021\\u20133"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["408682\/2022\\u20131"],"award-info":[{"award-number":["408682\/2022\\u20131"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118684","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:16:40Z","timestamp":1762539400000},"page":"118684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["New aminoadamantane derivatives as inhibitors of F13 envelope protein from mpox virus"],"prefix":"10.1016","volume":"193","author":[{"given":"Tha\u00eds de F\u00e1tima Silva","family":"Moraes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik Vinicius de Sousa","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Aparecida","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus S\u00e1 Magalh\u00e3es","family":"Serafim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3028-3187","authenticated-orcid":false,"given":"Felipe Alves","family":"Clarindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"de Melo Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edlia Bueno da Silva","family":"Menegatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erna Geessien","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edel Figueiredo","family":"Barbosa-Stancioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine Lima","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Guimar\u00e3es","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngelo","family":"de F\u00e1tima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana Grazziela Alves","family":"Coelho-dos-Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118684_bib1","unstructured":"World Health Organization, 2022-24 Mpox (Monkeypox) Outbreak: Global Trends, Available at: <\u3008https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/#4_Global_situation_update\u3009> Accessed on August 24, 2025."},{"issue":"10","key":"10.1016\/j.biopha.2025.118684_bib2","first-page":"267","article-title":"Epidemiological situation of monkeypox transmission by possible sexual contact: a systematic review","volume":"7","author":"Le\u00f3n-Figueroa","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118684_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102362","article-title":"The never-ending global emergence of viral zoonoses after COVID-19? The rising concern of monkeypox in Europe, North America and beyond","volume":"49","author":"Le\u00f3n-Figueroa","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118684_bib4","doi-asserted-by":"crossref","first-page":"o1874","DOI":"10.1136\/bmj.o1874","article-title":"Monkeypox: WHO declares a public health emergency of international concern","volume":"378","author":"Taylor","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2025.118684_bib5","unstructured":"CDC Mpox in the U.S. available at: <\u3008https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/world-map.html\u3009> Acessed on March 30, 2024."},{"issue":"22","key":"10.1016\/j.biopha.2025.118684_bib6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the advisory committee on immunization practices - United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118684_bib7","first-page":"372","article-title":"Human monkeypox disease (MPX)","volume":"30","author":"Farahat","year":"2022","journal-title":"Infez. Med."},{"issue":"11","key":"10.1016\/j.biopha.2025.118684_bib8","first-page":"369","article-title":"Antiviral treatment against monkeypox: a scoping review","volume":"7","author":"Ortiz-Saavedra","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2025.118684_bib9","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1021\/cr100264t","article-title":"The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives","volume":"113","author":"Wanka","year":"2013","journal-title":"Chem. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2025.118684_bib10","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.3390\/ijerph19053018","article-title":"Antiviral drugs in Influenza","volume":"19","author":"\u015awierczy\u0144ska","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.biopha.2025.118684_bib11","article-title":"New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19","volume":"v. 340","author":"de Almeida Marques","year":"2024","journal-title":"Virus Res."},{"issue":"6996","key":"10.1016\/j.biopha.2025.118684_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature02759","article-title":"The challenge of emerging and re-emerging infectious diseases","volume":"430","author":"Morens","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118684_bib13","article-title":"Natural Vaccinia virus infection: Diagnosis, isolation, and characterization","volume":"42","author":"Geessien Kroon","year":"2016","journal-title":"Curr. Protoc. Microbiol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118684_bib14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1073\/pnas.38.8.747","article-title":"Production of plaques in monolayer tissue cultures by single particles of an animal virus","volume":"38","author":"Dulbecco","year":"1952","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118684_bib15","unstructured":"ProTox 3.0 available at:\u3008https:\/\/tox.charite.de\/protox3\/\u3009."},{"key":"10.1016\/j.biopha.2025.118684_bib16","unstructured":"Pred-hERG 5.0 available at: <>\u3008https:\/\/predherg.labmol.com.br\/\u3009."},{"key":"10.1016\/j.biopha.2025.118684_bib17","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1007\/s00705-021-05230-8","article-title":"Methanol extract and N,N-dimethyltryptamine from Psychotria viridis Ruiz & Pav. inhibit in vitro the Zika virus infection","volume":"166","author":"Moraes","year":"2021","journal-title":"Arch. Virol."},{"key":"10.1016\/j.biopha.2025.118684_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155197","article-title":"Exploring the antiviral potential of justicidin B and four glycosylated lignans from Phyllanthus brasiliensis against Zika virus: A promising pharmacological approach","volume":"123","author":"Ferraz","year":"2024","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.biopha.2025.118684_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28536","article-title":"Ultrastructural analysis of monkeypox virus replication in Vero cells","volume":"95","author":"Witt","year":"2023","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118684_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/jm0603365","article-title":"Comparison of shape-matching and docking as virtual screening tools","volume":"50","author":"Hawkins","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118684_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.814","article-title":"Antibacterial activity of synthetic 1,3-bis(aryloxy)propan-2-amines against Gram-positive bacteria","volume":"8","author":"Serafim","year":"2019","journal-title":"MicrobiologyOpen"},{"key":"10.1016\/j.biopha.2025.118684_bib22","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL bioactivity database: an update","volume":"42","author":"Bento","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.biopha.2025.118684_bib23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/jm040163o","article-title":"A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction","volume":"48","author":"Rush","year":"2005","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118684_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/acs.jcim.3c01505","article-title":"Aminopyrimidine derivatives as multiflavivirus antiviral compounds identified from a consensus virtual screening approach","volume":"64","author":"Serafim","year":"2024","journal-title":"J. Chem. Inf. Model"},{"issue":"4","key":"10.1016\/j.biopha.2025.118684_bib25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and cambridge structural database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model"},{"issue":"1","key":"10.1016\/j.biopha.2025.118684_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118684_bib27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41564-025-01936-6","article-title":"Structural insights into tecovirimat antiviral activity and poxvirus resistance","volume":"10","author":"Vernuccio","year":"2025","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.biopha.2025.118684_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Bioinforma."},{"issue":"1","key":"10.1016\/j.biopha.2025.118684_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/pro.3280","article-title":"Improvements to the APBS biomolecular solvation software suite","volume":"27","author":"Jurrus","year":"2018","journal-title":"Protein Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118684_bib30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/prot.20660","article-title":"Very fast empirical prediction and rationalization of protein pKa values","volume":"61","author":"Li","year":"2005","journal-title":"Proteins"},{"issue":"4","key":"10.1016\/j.biopha.2025.118684_bib31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.biopha.2025.118684_bib32","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejmech.2018.03.024","volume":"150","author":"Vallone","year":"2018","journal-title":"Eur. J. Med Chem."},{"issue":"18","key":"10.1016\/j.biopha.2025.118684_bib33","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1039\/C6CP01555G","article-title":"Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power","volume":"18","author":"Wang","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"2","key":"10.1016\/j.biopha.2025.118684_bib34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/futurepharmacol3020022","article-title":"Synthetic curcumin analogues present antiflavivirus activity in vitro with potential multiflavivirus activity from a thiazolylhydrazone moiety","volume":"3","author":"Serafim","year":"2023","journal-title":"Future Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118684_bib35","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1021\/acs.jmedchem.0c02227","article-title":"Decision making in structure-based drug discovery: visual inspection of docking results","volume":"64","author":"Fischer","year":"2021","journal-title":"J. Med Chem."},{"issue":"20","key":"10.1016\/j.biopha.2025.118684_bib36","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118684_bib37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","article-title":"Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis","volume":"16","author":"Karagoz","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.biopha.2025.118684_bib38","unstructured":"NIAID: National Institute of Allergy and Infectious Diseases, The Antiviral Tecovirimat is Safe but Did Not Improve Clade I Mpox Resolution in Democratic Republic of the Congo. Available at: \u3008https:\/\/www.niaid.nih.gov\/news-events\/antiviral-tecovirimat-safe-did-not-improve-clade-i-mpox-resolution-democratic-republic\u3009 Acessed on: August 25, 2025."},{"issue":"8027","key":"10.1016\/j.biopha.2025.118684_bib39","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/d41586-024-02694-x","article-title":"Hopes dashed for drug aimed at monkeypox virus spreading in Africa","volume":"632","author":"Lenharo","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118684_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2019.06.005","article-title":"The development and approval of tecoviromat (TPOXX\u00ae), the first antiviral against smallpox","volume":"168","author":"Merchlinsky","year":"2019","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2025.118684_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade7646","article-title":"In vitro and in vivo efficacy of tecovirimat against a recently emerged 2022 monkeypox virus isolate","volume":"14","author":"Warner","year":"2022","journal-title":"Sci. Transl. Med"},{"issue":"2","key":"10.1016\/j.biopha.2025.118684_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107068","article-title":"Pharmacokinetics of tecovirimat in subjects with Mpox","volume":"63","author":"Tempestilli","year":"2024","journal-title":"Int J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2025.118684_bib43","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1056\/NEJMc2214921","article-title":"An mpox-related death in the United States","volume":"388","author":"Alarc\u00f3n","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2025.118684_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14022","article-title":"Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult","volume":"25","author":"Dammann","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118684_bib45","article-title":"Identification of tecovirimat resistance-associated mutations in human monkeypox virus\u2014Los Angeles County","volume":"67","author":"Garrigues","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.biopha.2025.118684_bib46","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.3201\/eid2912.231146","article-title":"Tecovirimat Resistance in Mpox Patients, United States, 2022-2023","volume":"29","author":"Smith","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118684_bib47","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1473-3099(23)00044-0","article-title":"Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection","volume":"23","author":"Stafford","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2025.118684_bib48","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1102609","article-title":"Placebo-controlled trial of amantadine for severe traumatic brain injury","volume":"366","author":"Giacino","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.biopha.2025.118684_bib49","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3390\/v2112409","article-title":"Development of ST-246\u00ae for Treatment of Poxvirus Infections","volume":"2","author":"Jordan","year":"2010","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.biopha.2025.118684_bib50","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1897\/07-541.1","article-title":"Hormesis: why it is important to toxicology and toxicologists","volume":"27","author":"Calabrese","year":"2008","journal-title":"Environ. Toxicol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118684_bib51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0960327112455069","article-title":"Hormesis: its impact on medicine and health","volume":"32","author":"Calabrese","year":"2013","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.biopha.2025.118684_bib52","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijpddr.2018.10.002","article-title":"Antoniana KU. Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity","volume":"25","author":"Aguiar","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"3","key":"10.1016\/j.biopha.2025.118684_bib53","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41564-025-01936-6","article-title":"Structural insights into tecovirimat antiviral activity and poxvirus resistance","volume":"10","author":"Vernuccio","year":"2025","journal-title":"Nat. Microbiol"},{"issue":"20","key":"10.1016\/j.biopha.2025.118684_bib54","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118684_bib55","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/v14091870","article-title":"A glance at the development and patent literature of tecovirimat: the first-in-class therapy for emerging monkeypox outbreak","volume":"14","author":"Almehmadi","year":"2022","journal-title":"Viruses"},{"issue":"28","key":"10.1016\/j.biopha.2025.118684_bib56","doi-asserted-by":"crossref","first-page":"2200503","DOI":"10.2807\/1560-7917.ES.2022.27.28.2200503","article-title":"Hospital clinic de barcelona monkeypox study group. Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022","volume":"27","author":"Peir\u00f3-Mestres","year":"2022","journal-title":"Eur. Surveill."},{"key":"10.1016\/j.biopha.2025.118684_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113485","article-title":"Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity","volume":"221","author":"Shiryaev","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118684_bib58","doi-asserted-by":"crossref","first-page":"495","DOI":"10.18388\/abp.2014_1870","article-title":"Antivirals--current trends in fighting influenza","volume":"61","author":"Kr\u00f3l","year":"2014","journal-title":"Acta Biochim Pol."},{"key":"10.1016\/j.biopha.2025.118684_bib59","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211002621","article-title":"A review: Mechanism of action of antiviral drugs","volume":"35","author":"Kausar","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118684_bib60","doi-asserted-by":"crossref","first-page":"13828","DOI":"10.3390\/ijms241813828","article-title":"Viroporins of Mpox Virus","volume":"24","author":"Basu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118684_bib61","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s42003-021-02866-9","article-title":"Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2","volume":"4","author":"Toft-Bertelsen","year":"2021","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118684_bib62","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-021-00558-8","article-title":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"18","key":"10.1016\/j.biopha.2025.118684_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00646-22","article-title":"Amantadine and rimantadine inhibit Hepatitis A virus replication through the induction of autophagy","volume":"96","author":"Sasaki-Tanaka","year":"2022","journal-title":"J. Virol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:48:55Z","timestamp":1777013335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225008789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":63,"alternative-id":["S0753332225008789"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118684","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New aminoadamantane derivatives as inhibitors of F13 envelope protein from mpox virus","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118684"}}